+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enovis Corp (ENOV) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 54 Pages
  • May 2023
  • GlobalData
  • ID: 5680611
Enovis Corp (ENOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Enovis Corp (Enovis), formerly Colfax Corp, is an innovation-driven medical technology company that provides medical technology products and services for musculoskeletal health, joint reconstruction, vascular health, and pain management. The company is also focused on developing clinically differentiated solutions. Its portfolio of products includes hot and cold therapy, rigid and soft orthopedic bracing, therapeutic shoes and inserts, bone growth stimulators, and vascular therapy systems; and other metals and metal alloys. The company serves commercial and governmental customers in the United States and other countries. The company has manufacturing, assembling, warehousing and engineering facilities in Europe, Asia, South America, and the Middle East. Enovis is headquartered in Annapolis, Maryland, the US.

Enovis Corp Key Recent Developments

May 04, 2023: Enovis Announces First Quarter 2023 Results
Apr 03, 2023: Enovis agrees to acquire foot and ankle company Novastep
Feb 27, 2023: Newsweek names Enovis as One of America's Greatest Workplaces for Diversity 2023
Feb 23, 2023: Enovis Announces Fourth Quarter and Full Year 2022 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Enovis Corp - Key Facts
  • Enovis Corp - Key Employees
  • Enovis Corp - Key Employee Biographies
  • Enovis Corp - Major Products and Services
  • Enovis Corp - History
  • Enovis Corp - Company Statement
  • Enovis Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Enovis Corp - Business Description
  • Business Segment: Prevention and Recovery
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Reconstructive
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Foreign Locations
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Enovis Corp - Corporate Strategy
  • Enovis Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Enovis Corp - Strengths
  • Enovis Corp - Weaknesses
  • Enovis Corp - Opportunities
  • Enovis Corp - Threats
  • Enovis Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
  • Enovis Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Enovis Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Enovis Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 04, 2023: Enovis Announces First Quarter 2023 Results
  • Apr 03, 2023: Enovis agrees to acquire foot and ankle company Novastep
  • Feb 27, 2023: Newsweek names Enovis as One of America’s Greatest Workplaces for Diversity 2023
  • Feb 23, 2023: Enovis Announces Fourth Quarter and Full Year 2022 Results
  • Nov 10, 2022: Enovis’ ARVIS Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting
  • Nov 02, 2022: Enovis Announces Third Quarter 2022 Results
  • Sep 30, 2022: Enovis celebrates opening of new Austin manufacturing facility to support company’s MedTech growth
  • Aug 04, 2022: Enovis Announces Second Quarter 2022 Results
  • Jun 30, 2022: Enovis Announces Chief Financial Officer Transition Plan
  • Jun 29, 2022: Enovis announces partnership with Kelvi for innovative hot and cold therapies
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Enovis Corp, Key Facts
  • Enovis Corp, Key Employees
  • Enovis Corp, Key Employee Biographies
  • Enovis Corp, Major Products and Services
  • Enovis Corp, History
  • Enovis Corp, Subsidiaries
  • Enovis Corp, Key Competitors
  • Enovis Corp, Ratios based on current share price
  • Enovis Corp, Annual Ratios
  • Enovis Corp, Interim Ratios
  • Enovis Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Enovis Corp, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Enovis Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Enovis Corp, Performance Chart (2018 - 2022)
  • Enovis Corp, Ratio Charts
  • Enovis Corp, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Enovis Corp, Medical Equipment, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Ossur hf
  • DePuy Synthes Inc
  • Breg Inc